Home › Companies › WEST PHARMACEUTICAL SERVICES INC. › 2023-2024

WEST PHARMACEUTICAL SERVICES INC. 2023-2024 Proxy Voting Records

Compiled from SEC Form N-PX filings and WEST PHARMACEUTICAL SERVICES INC.’s Form 8-K, filed April 26, 2024 (Item 5.07 on EDGAR). Page generated October 14, 2026.

  • 16Reported items
  • 692Asset managers
  • 12,433Fund votes
  • April 23, 2024Meeting date

Results at a glance

Meeting of April 23, 2024: 15 items on WEST PHARMACEUTICAL SERVICES INC.’s Form 8-K, filed April 26, 2024: 11 elected · 4 approved.

Material dissent

None.

Material dissent: a director nominee under 80% of the votes cast, say-on-pay under 70%, any other item the board put forward under 80%, or a shareholder proposal with more than 50%, on the company’s own Form 8-K tally. How this is decided

Proxy season: 2023-2024 2024-2025 2025-2026

Explore WEST PHARMACEUTICAL SERVICES INC. in the interactive database Compare manager voting policies

Official 2023-2024 meeting results reported by WEST PHARMACEUTICAL SERVICES INC.

These tallies are WEST PHARMACEUTICAL SERVICES INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed April 26, 2024 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

WEST PHARMACEUTICAL SERVICES INC. — official shareholder meeting results, meeting held April 23, 2024
Ballot itemForAgainst AbstainWithheldBroker non-votesSupport (of votes cast)Reported outcomeVoting standard
Elect Director: Mark A. Buthman 64,065,422781,915124,206 --2,204,148 99%Elected—
Elect Director: William F. Feehery 62,874,5251,981,149115,869 --2,204,148 97%Elected—
Elect Director: Robert F. Friel 61,754,3573,100,948116,238 --2,204,148 95%Elected—
Elect Director: Eric M. Green 59,690,6492,700,6412,580,253 --2,204,148 96%Elected—
Elect Director: Thomas W. Hofmann 60,144,4704,674,914152,159 --2,204,148 93%Elected—
Elect Director: Molly E. Joseph 64,459,745457,58454,214 --2,204,148 99.2%Elected—
Elect Director: Deborah L. V. Keller 53,932,2348,407,0562,632,253 --2,204,148 87%Elected—
Elect Director: Myla P. Lai-Goldman 64,413,765520,16337,615 --2,204,148 99.1%Elected—
Elect Director: Stephen H. Lockhart 64,631,871215,445124,227 --2,204,148 99.6%Elected—
Elect Director: Douglas A. Michels 60,971,8173,883,389116,337 --2,204,148 94%Elected—
Elect Director: Paolo Pucci 59,965,0054,889,598116,940 --2,204,148 92%Elected—
Proposal 2: Our shareholders approved, on an advisory basis, our named executive officer compensation by the following vote: 61,974,3152,926,26370,965 --2,204,148 95%Approved—
Proposal 3: Our shareholders approved to amend and restate our articles of incorporation to eliminate the supermajority transaction requirement by the following vote: 64,521,017434,65315,873 --2,204,148 99.3%Approved—
Proposal 4: Our shareholders approved to amend and restate our articles of incorporation to eliminate the supermajority amendment requirement by the following vote: 2 64,516,512423,86731,164 --2,204,148 99.3%Approved—
Proposal 5: Our shareholders ratified the selection of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the 2024 fiscal year by the following vote: 61,537,5115,501,551136,629 ---- 92%Approved—

Source: WEST PHARMACEUTICAL SERVICES INC., Form 8-K, filed with the SEC on April 26, 2024 — read the filing on EDGAR.

How asset managers voted at the WEST PHARMACEUTICAL SERVICES INC. 2023-2024 meeting

Each item below shows how the 692 asset managers that disclosed a WEST PHARMACEUTICAL SERVICES INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of WEST PHARMACEUTICAL SERVICES INC.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.

1. Elect Director: Deborah L. V. Keller

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 3 wordings of this item as funds reported it.

87% Majority: yes · of votes cast

FOR 87%
FOR: 53,932,234AGAINST: 8,407,056
Details: description as filed, official tally, votes by 158 asset managers

Description as filed by funds: Election of Directors: Deborah L. V. Keller

WEST PHARMACEUTICAL SERVICES INC.’s own tally for this item (“Elect Director: Deborah L. V. Keller”): 53,932,234 for, 8,407,056 against, per its Form 8-K filed April 26, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “Proposal 1: Our shareholders elected the following directors to serve on our Board until the 2025 Annual Meeting of Shareholders by the following vote:”
Support: 87% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 158 asset managers below reported 27,038,370 for, 2,120,795 against, 2 withheld, 20,341 abstained.

FOR
FOR: 27,038,370AGAINST: 2,120,795ABSTAIN: 20,341WITHHOLD: 2
Largest asset managers voting on “Election of Directors: Deborah L. V. Keller” at WEST PHARMACEUTICAL SERVICES INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Vanguard8,724,5070 00For
BlackRock3,543,7000 00For
T. Rowe Price2,306,5240 00For
Fidelity1,888,1930 00For
FRANKLIN MANAGED TRUST1,322,7810 00For
State Street284787,113 00Against
BARON INVESTMENT FUNDS TRUST (f/k/a BARON ASSET FUND)702,4040 00For
Brown Advisory Funds664,5640 00For
Invesco592,3410 00For
MFS538,3490 00For
Artisan528,7860 00For
ProShares502,7380 00For
JPMorgan470,9420 00For
TIAA460,5390 00For
Charles Schwab0434,227 00Against
Jackson National339,8700 00For
Virtus308,3690 00For
FRANKLIN STRATEGIC SERIES0305,633 00Against
Neuberger Berman284,9440 00For
Columbia Threadneedle279,6890 00For
CARILLON SERIES TRUST253,8180 00For
Waddell & Reed235,1870 00For
Bridge Builder Trust210,67712,448 00Mixed
Victory Capital203,6430 00For
Prudential/PGIM203,1440 00For

Showing the 25 largest of 158 asset managers. See all 158 in the interactive database.

2. Elect Director: Douglas A. Michels

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 3 wordings of this item as funds reported it.

94% Majority: yes · of votes cast

FOR 94%
FOR: 60,971,817AGAINST: 3,883,389
Details: description as filed, official tally, votes by 158 asset managers

Description as filed by funds: Election of Directors: Douglas A. Michels

WEST PHARMACEUTICAL SERVICES INC.’s own tally for this item (“Elect Director: Douglas A. Michels”): 60,971,817 for, 3,883,389 against, per its Form 8-K filed April 26, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “Proposal 1: Our shareholders elected the following directors to serve on our Board until the 2025 Annual Meeting of Shareholders by the following vote:”
Support: 94% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 158 asset managers below reported 29,042,678 for, 116,488 against, 1 withheld, 20,341 abstained.

FOR
FOR: 29,042,678AGAINST: 116,488ABSTAIN: 20,341WITHHOLD: 1
Largest asset managers voting on “Election of Directors: Douglas A. Michels” at WEST PHARMACEUTICAL SERVICES INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Vanguard8,724,5070 00For
BlackRock3,543,7000 00For
T. Rowe Price2,306,5240 00For
Fidelity1,888,1930 00For
FRANKLIN MANAGED TRUST1,322,7810 00For
State Street787,32374 00For
BARON INVESTMENT FUNDS TRUST (f/k/a BARON ASSET FUND)702,4040 00For
Brown Advisory Funds664,5640 00For
Invesco592,3410 00For
MFS538,3490 00For
Artisan528,7860 00For
ProShares502,7380 00For
JPMorgan470,9420 00For
TIAA460,5390 00For
Charles Schwab434,2270 00For
Jackson National339,8700 00For
Virtus308,3690 00For
FRANKLIN STRATEGIC SERIES305,6330 00For
Neuberger Berman284,9440 00For
Columbia Threadneedle279,6890 00For
CARILLON SERIES TRUST253,8180 00For
Waddell & Reed235,1870 00For
Bridge Builder Trust210,67712,448 00Mixed
Victory Capital203,6430 00For
Prudential/PGIM203,1440 00For

Showing the 25 largest of 158 asset managers. See all 158 in the interactive database.

3. Elect Director: Eric M. Green

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 3 wordings of this item as funds reported it.

96% Majority: yes · of votes cast

FOR 96%
FOR: 59,690,649AGAINST: 2,700,641
Details: description as filed, official tally, votes by 158 asset managers

Description as filed by funds: Election of Directors: Eric M. Green

WEST PHARMACEUTICAL SERVICES INC.’s own tally for this item (“Elect Director: Eric M. Green”): 59,690,649 for, 2,700,641 against, per its Form 8-K filed April 26, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “Proposal 1: Our shareholders elected the following directors to serve on our Board until the 2025 Annual Meeting of Shareholders by the following vote:”
Support: 96% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 158 asset managers below reported 29,112,903 for, 46,262 against, 2 withheld, 20,341 abstained.

FOR
FOR: 29,112,903AGAINST: 46,262ABSTAIN: 20,341WITHHOLD: 2
Largest asset managers voting on “Election of Directors: Eric M. Green” at WEST PHARMACEUTICAL SERVICES INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Vanguard8,724,5070 00For
BlackRock3,543,7000 00For
T. Rowe Price2,306,5240 00For
Fidelity1,888,1930 00For
FRANKLIN MANAGED TRUST1,322,7810 00For
State Street787,36829 00For
BARON INVESTMENT FUNDS TRUST (f/k/a BARON ASSET FUND)702,4040 00For
Brown Advisory Funds664,5640 00For
Invesco592,3410 00For
MFS538,3490 00For
Artisan528,7860 00For
ProShares502,7380 00For
JPMorgan470,9420 00For
TIAA460,5390 00For
Charles Schwab434,2270 00For
Jackson National339,8700 00For
Virtus308,3690 00For
FRANKLIN STRATEGIC SERIES305,6330 00For
Neuberger Berman284,9440 00For
Columbia Threadneedle279,6890 00For
CARILLON SERIES TRUST253,8180 00For
Waddell & Reed235,1870 00For
Bridge Builder Trust223,1250 00For
Victory Capital203,6430 00For
Prudential/PGIM203,1440 00For

Showing the 25 largest of 158 asset managers. See all 158 in the interactive database.

4. Elect Director: Mark A. Buthman

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 3 wordings of this item as funds reported it.

99% Majority: yes · of votes cast

FOR 99%
FOR: 64,065,422AGAINST: 781,915
Details: description as filed, official tally, votes by 158 asset managers

Description as filed by funds: Election of Directors: Mark A. Buthman

WEST PHARMACEUTICAL SERVICES INC.’s own tally for this item (“Elect Director: Mark A. Buthman”): 64,065,422 for, 781,915 against, per its Form 8-K filed April 26, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “Proposal 1: Our shareholders elected the following directors to serve on our Board until the 2025 Annual Meeting of Shareholders by the following vote:”
Support: 99% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 158 asset managers below reported 29,159,057 for, 108 against, 2 withheld, 20,341 abstained.

FOR
FOR: 29,159,057AGAINST: 108ABSTAIN: 20,341WITHHOLD: 2
Largest asset managers voting on “Election of Directors: Mark A. Buthman” at WEST PHARMACEUTICAL SERVICES INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Vanguard8,724,5070 00For
BlackRock3,543,7000 00For
T. Rowe Price2,306,5240 00For
Fidelity1,888,1930 00For
FRANKLIN MANAGED TRUST1,322,7810 00For
State Street787,36829 00For
BARON INVESTMENT FUNDS TRUST (f/k/a BARON ASSET FUND)702,4040 00For
Brown Advisory Funds664,5640 00For
Invesco592,3410 00For
MFS538,3490 00For
Artisan528,7860 00For
ProShares502,7380 00For
JPMorgan470,9420 00For
TIAA460,5390 00For
Charles Schwab434,2270 00For
Jackson National339,8700 00For
Virtus308,3690 00For
FRANKLIN STRATEGIC SERIES305,6330 00For
Neuberger Berman284,9440 00For
Columbia Threadneedle279,6890 00For
CARILLON SERIES TRUST253,8180 00For
Waddell & Reed235,1870 00For
Bridge Builder Trust223,1250 00For
Victory Capital203,6430 00For
Prudential/PGIM203,1440 00For

Showing the 25 largest of 158 asset managers. See all 158 in the interactive database.

5. Elect Director: Molly E. Joseph

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 3 wordings of this item as funds reported it.

99.2% Majority: yes · of votes cast

FOR 99.2%
FOR: 64,459,745AGAINST: 457,584
Details: description as filed, official tally, votes by 158 asset managers

Description as filed by funds: Election of Directors: Molly E. Joseph

WEST PHARMACEUTICAL SERVICES INC.’s own tally for this item (“Elect Director: Molly E. Joseph”): 64,459,745 for, 457,584 against, per its Form 8-K filed April 26, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “Proposal 1: Our shareholders elected the following directors to serve on our Board until the 2025 Annual Meeting of Shareholders by the following vote:”
Support: 99.2% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 158 asset managers below reported 29,128,209 for, 15,889 against, 1 withheld, 35,409 abstained.

FOR
FOR: 29,128,209AGAINST: 15,889ABSTAIN: 35,409WITHHOLD: 1
Largest asset managers voting on “Election of Directors: Molly E. Joseph” at WEST PHARMACEUTICAL SERVICES INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Vanguard8,724,5070 00For
BlackRock3,543,7000 00For
T. Rowe Price2,306,5240 00For
Fidelity1,888,1930 00For
FRANKLIN MANAGED TRUST1,322,7810 00For
State Street787,37225 00For
BARON INVESTMENT FUNDS TRUST (f/k/a BARON ASSET FUND)702,4040 00For
Brown Advisory Funds664,5640 00For
Invesco592,3410 00For
MFS538,3490 00For
Artisan528,7860 00For
ProShares502,7380 00For
JPMorgan470,9420 00For
TIAA460,5390 00For
Charles Schwab434,2270 00For
Jackson National339,8700 00For
Virtus308,3690 00For
FRANKLIN STRATEGIC SERIES305,6330 00For
Neuberger Berman284,9440 00For
Columbia Threadneedle279,6890 00For
CARILLON SERIES TRUST253,8180 00For
Waddell & Reed235,1870 00For
Bridge Builder Trust223,1250 00For
Victory Capital203,6430 00For
Prudential/PGIM203,1440 00For

Showing the 25 largest of 158 asset managers. See all 158 in the interactive database.

6. Elect Director: Myla P. Lai-Goldman

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 3 wordings of this item as funds reported it.

99.1% Majority: yes · of votes cast

FOR 99.1%
FOR: 64,413,765AGAINST: 520,163
Details: description as filed, official tally, votes by 158 asset managers

Description as filed by funds: Election of Directors: Myla P. Lai-Goldman

WEST PHARMACEUTICAL SERVICES INC.’s own tally for this item (“Elect Director: Myla P. Lai-Goldman”): 64,413,765 for, 520,163 against, per its Form 8-K filed April 26, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “Proposal 1: Our shareholders elected the following directors to serve on our Board until the 2025 Annual Meeting of Shareholders by the following vote:”
Support: 99.1% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 158 asset managers below reported 29,159,097 for, 69 against, 1 withheld, 20,341 abstained.

FOR
FOR: 29,159,097AGAINST: 69ABSTAIN: 20,341WITHHOLD: 1
Largest asset managers voting on “Election of Directors: Myla P. Lai-Goldman” at WEST PHARMACEUTICAL SERVICES INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Vanguard8,724,5070 00For
BlackRock3,543,7000 00For
T. Rowe Price2,306,5240 00For
Fidelity1,888,1930 00For
FRANKLIN MANAGED TRUST1,322,7810 00For
State Street787,37225 00For
BARON INVESTMENT FUNDS TRUST (f/k/a BARON ASSET FUND)702,4040 00For
Brown Advisory Funds664,5640 00For
Invesco592,3410 00For
MFS538,3490 00For
Artisan528,7860 00For
ProShares502,7380 00For
JPMorgan470,9420 00For
TIAA460,5390 00For
Charles Schwab434,2270 00For
Jackson National339,8700 00For
Virtus308,3690 00For
FRANKLIN STRATEGIC SERIES305,6330 00For
Neuberger Berman284,9440 00For
Columbia Threadneedle279,6890 00For
CARILLON SERIES TRUST253,8180 00For
Waddell & Reed235,1870 00For
Bridge Builder Trust223,1250 00For
Victory Capital203,6430 00For
Prudential/PGIM203,1440 00For

Showing the 25 largest of 158 asset managers. See all 158 in the interactive database.

7. Elect Director: Paolo Pucci

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 3 wordings of this item as funds reported it.

92% Majority: yes · of votes cast

FOR 92%
FOR: 59,965,005AGAINST: 4,889,598
Details: description as filed, official tally, votes by 158 asset managers

Description as filed by funds: Election of Directors: Paolo Pucci

WEST PHARMACEUTICAL SERVICES INC.’s own tally for this item (“Elect Director: Paolo Pucci”): 59,965,005 for, 4,889,598 against, per its Form 8-K filed April 26, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “Proposal 1: Our shareholders elected the following directors to serve on our Board until the 2025 Annual Meeting of Shareholders by the following vote:”
Support: 92% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 158 asset managers below reported 28,244,231 for, 914,935 against, 1 withheld, 20,341 abstained.

FOR
FOR: 28,244,231AGAINST: 914,935ABSTAIN: 20,341WITHHOLD: 1
Largest asset managers voting on “Election of Directors: Paolo Pucci” at WEST PHARMACEUTICAL SERVICES INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Vanguard8,724,5070 00For
BlackRock3,543,7000 00For
T. Rowe Price2,306,5240 00For
Fidelity1,888,1930 00For
FRANKLIN MANAGED TRUST1,322,7810 00For
State Street284787,113 00Against
BARON INVESTMENT FUNDS TRUST (f/k/a BARON ASSET FUND)702,4040 00For
Brown Advisory Funds664,5640 00For
Invesco592,3410 00For
MFS538,3490 00For
Artisan528,7860 00For
ProShares502,7380 00For
JPMorgan470,9420 00For
TIAA460,5390 00For
Charles Schwab434,2270 00For
Jackson National339,8700 00For
Virtus308,3690 00For
FRANKLIN STRATEGIC SERIES305,6330 00For
Neuberger Berman284,9440 00For
Columbia Threadneedle279,6890 00For
CARILLON SERIES TRUST253,8180 00For
Waddell & Reed235,1870 00For
Bridge Builder Trust210,67712,448 00Mixed
Victory Capital203,6430 00For
Prudential/PGIM203,1440 00For

Showing the 25 largest of 158 asset managers. See all 158 in the interactive database.

8. Elect Director: Robert F. Friel

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 3 wordings of this item as funds reported it.

95% Majority: yes · of votes cast

FOR 95%
FOR: 61,754,357AGAINST: 3,100,948
Details: description as filed, official tally, votes by 158 asset managers

Description as filed by funds: Election of Directors: Robert F. Friel

WEST PHARMACEUTICAL SERVICES INC.’s own tally for this item (“Elect Director: Robert F. Friel”): 61,754,357 for, 3,100,948 against, per its Form 8-K filed April 26, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “Proposal 1: Our shareholders elected the following directors to serve on our Board until the 2025 Annual Meeting of Shareholders by the following vote:”
Support: 95% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 158 asset managers below reported 29,021,107 for, 138,059 against, 1 withheld, 20,341 abstained.

FOR
FOR: 29,021,107AGAINST: 138,059ABSTAIN: 20,341WITHHOLD: 1
Largest asset managers voting on “Election of Directors: Robert F. Friel” at WEST PHARMACEUTICAL SERVICES INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Vanguard8,724,5070 00For
BlackRock3,543,7000 00For
T. Rowe Price2,306,5240 00For
Fidelity1,888,1930 00For
FRANKLIN MANAGED TRUST1,322,7810 00For
State Street787,34453 00For
BARON INVESTMENT FUNDS TRUST (f/k/a BARON ASSET FUND)702,4040 00For
Brown Advisory Funds664,5640 00For
Invesco592,3410 00For
MFS538,3490 00For
Artisan528,7860 00For
ProShares502,7380 00For
JPMorgan470,9420 00For
TIAA460,5390 00For
Charles Schwab434,2270 00For
Jackson National339,8700 00For
Virtus308,3690 00For
FRANKLIN STRATEGIC SERIES305,6330 00For
Neuberger Berman284,9440 00For
Columbia Threadneedle279,6890 00For
CARILLON SERIES TRUST253,8180 00For
Waddell & Reed235,1870 00For
Bridge Builder Trust210,67712,448 00Mixed
Victory Capital203,6430 00For
Prudential/PGIM203,1440 00For

Showing the 25 largest of 158 asset managers. See all 158 in the interactive database.

9. Elect Director: Stephen H. Lockhart

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 3 wordings of this item as funds reported it.

99.6% Majority: yes · of votes cast

FOR 99.6%
FOR: 64,631,871AGAINST: 215,445
Details: description as filed, official tally, votes by 158 asset managers

Description as filed by funds: Election of Directors: Stephen H. Lockhart

WEST PHARMACEUTICAL SERVICES INC.’s own tally for this item (“Elect Director: Stephen H. Lockhart”): 64,631,871 for, 215,445 against, per its Form 8-K filed April 26, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “Proposal 1: Our shareholders elected the following directors to serve on our Board until the 2025 Annual Meeting of Shareholders by the following vote:”
Support: 99.6% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 158 asset managers below reported 29,159,096 for, 69 against, 2 withheld, 20,341 abstained.

FOR
FOR: 29,159,096AGAINST: 69ABSTAIN: 20,341WITHHOLD: 2
Largest asset managers voting on “Election of Directors: Stephen H. Lockhart” at WEST PHARMACEUTICAL SERVICES INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Vanguard8,724,5070 00For
BlackRock3,543,7000 00For
T. Rowe Price2,306,5240 00For
Fidelity1,888,1930 00For
FRANKLIN MANAGED TRUST1,322,7810 00For
State Street787,37225 00For
BARON INVESTMENT FUNDS TRUST (f/k/a BARON ASSET FUND)702,4040 00For
Brown Advisory Funds664,5640 00For
Invesco592,3410 00For
MFS538,3490 00For
Artisan528,7860 00For
ProShares502,7380 00For
JPMorgan470,9420 00For
TIAA460,5390 00For
Charles Schwab434,2270 00For
Jackson National339,8700 00For
Virtus308,3690 00For
FRANKLIN STRATEGIC SERIES305,6330 00For
Neuberger Berman284,9440 00For
Columbia Threadneedle279,6890 00For
CARILLON SERIES TRUST253,8180 00For
Waddell & Reed235,1870 00For
Bridge Builder Trust223,1250 00For
Victory Capital203,6430 00For
Prudential/PGIM203,1440 00For

Showing the 25 largest of 158 asset managers. See all 158 in the interactive database.

10. Elect Director: Thomas W. Hofmann

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 3 wordings of this item as funds reported it.

93% Majority: yes · of votes cast

FOR 93%
FOR: 60,144,470AGAINST: 4,674,914
Details: description as filed, official tally, votes by 158 asset managers

Description as filed by funds: Election of Directors: Thomas W. Hofmann

WEST PHARMACEUTICAL SERVICES INC.’s own tally for this item (“Elect Director: Thomas W. Hofmann”): 60,144,470 for, 4,674,914 against, per its Form 8-K filed April 26, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “Proposal 1: Our shareholders elected the following directors to serve on our Board until the 2025 Annual Meeting of Shareholders by the following vote:”
Support: 93% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 158 asset managers below reported 29,080,560 for, 78,606 against, 1 withheld, 20,341 abstained.

FOR
FOR: 29,080,560AGAINST: 78,606ABSTAIN: 20,341WITHHOLD: 1
Largest asset managers voting on “Election of Directors: Thomas W. Hofmann” at WEST PHARMACEUTICAL SERVICES INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Vanguard8,724,5070 00For
BlackRock3,543,7000 00For
T. Rowe Price2,306,5240 00For
Fidelity1,888,1930 00For
FRANKLIN MANAGED TRUST1,322,7810 00For
State Street787,35146 00For
BARON INVESTMENT FUNDS TRUST (f/k/a BARON ASSET FUND)702,4040 00For
Brown Advisory Funds664,5640 00For
Invesco592,3410 00For
MFS538,3490 00For
Artisan528,7860 00For
ProShares502,7380 00For
JPMorgan470,9420 00For
TIAA460,5390 00For
Charles Schwab434,2270 00For
Jackson National339,8700 00For
Virtus308,3690 00For
FRANKLIN STRATEGIC SERIES305,6330 00For
Neuberger Berman284,9440 00For
Columbia Threadneedle279,6890 00For
CARILLON SERIES TRUST253,8180 00For
Waddell & Reed235,1870 00For
Bridge Builder Trust210,67712,448 00Mixed
Victory Capital203,6430 00For
Prudential/PGIM203,1440 00For

Showing the 25 largest of 158 asset managers. See all 158 in the interactive database.

11. Elect Director: William F. Feehery

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 3 wordings of this item as funds reported it.

97% Majority: yes · of votes cast

FOR 97%
FOR: 62,874,525AGAINST: 1,981,149
Details: description as filed, official tally, votes by 158 asset managers

Description as filed by funds: Election of Directors: William F. Feehery

WEST PHARMACEUTICAL SERVICES INC.’s own tally for this item (“Elect Director: William F. Feehery”): 62,874,525 for, 1,981,149 against, per its Form 8-K filed April 26, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “Proposal 1: Our shareholders elected the following directors to serve on our Board until the 2025 Annual Meeting of Shareholders by the following vote:”
Support: 97% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 158 asset managers below reported 29,129,020 for, 30,146 against, 1 withheld, 20,341 abstained.

FOR
FOR: 29,129,020AGAINST: 30,146ABSTAIN: 20,341WITHHOLD: 1
Largest asset managers voting on “Election of Directors: William F. Feehery” at WEST PHARMACEUTICAL SERVICES INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Vanguard8,724,5070 00For
BlackRock3,543,7000 00For
T. Rowe Price2,306,5240 00For
Fidelity1,888,1930 00For
FRANKLIN MANAGED TRUST1,322,7810 00For
State Street787,35146 00For
BARON INVESTMENT FUNDS TRUST (f/k/a BARON ASSET FUND)702,4040 00For
Brown Advisory Funds664,5640 00For
Invesco592,3410 00For
MFS538,3490 00For
Artisan528,7860 00For
ProShares502,7380 00For
JPMorgan470,9420 00For
TIAA460,5390 00For
Charles Schwab434,2270 00For
Jackson National339,8700 00For
Virtus308,3690 00For
FRANKLIN STRATEGIC SERIES305,6330 00For
Neuberger Berman284,9440 00For
Columbia Threadneedle279,6890 00For
CARILLON SERIES TRUST253,8180 00For
Waddell & Reed235,1870 00For
Bridge Builder Trust210,67712,448 00Mixed
Victory Capital203,6430 00For
Prudential/PGIM203,1440 00For

Showing the 25 largest of 158 asset managers. See all 158 in the interactive database.

12. Proposal 3: Our shareholders approved to amend and restate our articles of incorporation to eliminate the supermajority…

Official resultCORPORATE GOVERNANCEReported outcome: Approved

Combines 4 wordings of this item as funds reported it.

99.3% Approved · of votes cast

FOR 99.3%
FOR: 64,521,017AGAINST: 434,653
Details: description as filed, official tally, votes by 158 asset managers

Description as filed by funds: Amend and Restate Our Amended and Restated Articles of Incorporation to Eliminate Supermajority Transaction Requirement;

WEST PHARMACEUTICAL SERVICES INC.’s own tally for this item (“Proposal 3: Our shareholders approved to amend and restate our articles of incorporation to eliminate the supermajority transaction requirement by the following vote:”): 64,521,017 for, 434,653 against — passed, per its Form 8-K filed April 26, 2024 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “Proposal 3: Our shareholders approved to amend and restate our articles of incorporation to eliminate the supermajority transaction requirement by the following vote:”
Support: 99.3% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 158 asset managers below reported 29,179,147 for, 2 against, 2 withheld, 357 abstained.

FOR
FOR: 29,179,147AGAINST: 2ABSTAIN: 357WITHHOLD: 2
Largest asset managers voting on “Amend and Restate Our Amended and Restated Articles of Incorporation to Eliminate Supermajority Transaction Re” at WEST PHARMACEUTICAL SERVICES INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Vanguard8,724,5070 00For
BlackRock3,543,7000 00For
T. Rowe Price2,306,5240 00For
Fidelity1,888,1930 00For
FRANKLIN MANAGED TRUST1,322,7810 00For
State Street787,3970 00For
BARON INVESTMENT FUNDS TRUST (f/k/a BARON ASSET FUND)702,4040 00For
Brown Advisory Funds664,5640 00For
Invesco592,3410 00For
MFS538,3490 00For
Artisan528,7860 00For
ProShares502,7380 00For
JPMorgan470,9420 00For
TIAA460,5390 00For
Charles Schwab434,2270 00For
Jackson National339,8700 00For
Virtus308,3690 00For
FRANKLIN STRATEGIC SERIES305,6330 00For
Neuberger Berman284,9440 00For
Columbia Threadneedle279,6890 00For
CARILLON SERIES TRUST253,8180 00For
Waddell & Reed235,1870 00For
Bridge Builder Trust223,1250 00For
Victory Capital203,6430 00For
Prudential/PGIM203,1440 00For

Showing the 25 largest of 158 asset managers. See all 158 in the interactive database.

13. Amend and Restate Our Amended and Restated Articles of Incorporation to Eliminate Supermajority Amendment Requirement;

No official matchCORPORATE GOVERNANCE

Combines 3 wordings of this item as funds reported it.

99.9% of fund votes cast · no official result

FOR
Details: votes by 156 asset managers

The 156 asset managers below reported 29,167,047 for, 2 against, 2 withheld. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 29,167,047AGAINST: 2WITHHOLD: 2
Largest asset managers voting on “Amend and Restate Our Amended and Restated Articles of Incorporation to Eliminate Supermajority Amendment Requ” at WEST PHARMACEUTICAL SERVICES INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Vanguard8,724,5070 00For
BlackRock3,543,7000 00For
T. Rowe Price2,306,5240 00For
Fidelity1,888,1930 00For
FRANKLIN MANAGED TRUST1,322,7810 00For
State Street787,3970 00For
BARON INVESTMENT FUNDS TRUST (f/k/a BARON ASSET FUND)702,4040 00For
Brown Advisory Funds664,5640 00For
Invesco592,3410 00For
MFS538,3490 00For
Artisan528,7860 00For
ProShares502,7380 00For
JPMorgan470,9420 00For
TIAA460,5390 00For
Charles Schwab434,2270 00For
Jackson National339,8700 00For
Virtus308,3690 00For
FRANKLIN STRATEGIC SERIES305,6330 00For
Neuberger Berman284,9440 00For
Columbia Threadneedle279,6890 00For
CARILLON SERIES TRUST253,8180 00For
Waddell & Reed235,1870 00For
Bridge Builder Trust223,1250 00For
Victory Capital203,6430 00For
Prudential/PGIM203,1440 00For

Showing the 25 largest of 156 asset managers. See all 156 in the interactive database.

14. Proposal 2: Our shareholders approved, on an advisory basis, our named executive officer compensation by the following…

Official resultFund totals may overlapSECTION 14A SAY-ON-PAY VOTESReported outcome: Approved

Combines 12 wordings of this item as funds reported it.

95% Approved · of votes cast

FOR 95%
FOR: 61,974,315AGAINST: 2,926,263
Details: description as filed, official tally, votes by 684 asset managers

Description as filed by funds: Advisory vote to approve named executive officer compensation;

WEST PHARMACEUTICAL SERVICES INC.’s own tally for this item (“Proposal 2: Our shareholders approved, on an advisory basis, our named executive officer compensation by the following vote:”): 61,974,315 for, 2,926,263 against — passed, per its Form 8-K filed April 26, 2024 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “Proposal 2: Our shareholders approved, on an advisory basis, our named executive officer compensation by the following vote:”
Support: 95% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports: 156 asset managers voting on “Advisory vote to approve named executive officer compensation;” at WEST PHARMACEUTICAL SERVICES INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Vanguard8,724,5070 00For
BlackRock3,543,7000 00For
Artisan2,391,3940 00For
T. Rowe Price2,306,5240 00For
Fidelity1,888,1930 00For
FRANKLIN MANAGED TRUST1,322,7810 00For
State Street787,3970 00For
BARON INVESTMENT FUNDS TRUST (f/k/a BARON ASSET FUND)702,4040 00For
Brown Advisory Funds664,5640 00For
Invesco592,3410 00For
MFS538,3490 00For
ProShares502,7380 00For
JPMorgan470,9420 00For
TIAA460,5390 00For
Charles Schwab434,2270 00For
Jackson National339,8700 00For
Virtus308,3690 00For
FRANKLIN STRATEGIC SERIES305,6330 00For
Neuberger Berman284,9440 00For
Columbia Threadneedle279,6890 00For
CARILLON SERIES TRUST253,8180 00For
Waddell & Reed235,1870 00For
Bridge Builder Trust223,1250 00For
Victory Capital203,6430 00For
Prudential/PGIM203,1440 00For

Fund voting reports, all 156 managers: 30,946,237 for, 89,187 against, 2 withheld, 6,606 abstained. Showing the 25 largest; see all in the interactive database.

Institutional-manager reports: 560 asset managers voting on “Advisory vote to approve named executive officer compensation;” at WEST PHARMACEUTICAL SERVICES INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Lazard4,000,0000 00For
New York Life4,000,0000 00For
T. Rowe Price3,395,7870 00For
BlackRock2,906,3331,291 00For
APG Asset Management US Inc.2,411,3400 00For
FRANKLIN ADVISERS INC2,224,1580 00For
State Street2,010,9940 00For
Walter Scott & Partners Ltd1,715,5670 00For
GEODE CAPITAL MANAGEMENT, LLC1,683,3590 00For
BROWN ADVISORY INC1,580,4350 00For
Durable Capital Partners LP1,067,8510 00For
BAMCO INC /NY/791,7480 00For
JPMorgan766,6140 00For
Citadel735,9110 00For
MASSACHUSETTS FINANCIAL SERVICES CO /MA/724,3930 00For
Invesco683,0360 00For
Idaho Trust Bank610,0000 00For
AllianceBernstein580,3540 00For
Findlay Park Partners LLP543,1060 00For
Nuveen535,0260 00For
Neuberger Berman485,5290 00For
Charles Schwab438,1690 00For
AustralianSuper Pty Ltd431,1580 00For
Legal & General Investment Management Ltd0418,201 00Against
MELLON INVESTMENTS Corp406,9230 00For

Institutional-manager reports, all 560 managers: 46,798,464 for, 1,679,840 against, 985 abstained, 9,307 not voted, 1,167 unknown. Showing the 25 largest; see all in the interactive database.

15. Proposal 5: Our shareholders ratified the selection of PricewaterhouseCoopers LLP as our independent registered public…

Official resultAUDIT-RELATEDReported outcome: Approved

Combines 9 wordings of this item as funds reported it.

92% Approved · of votes cast

FOR 92%
FOR: 61,537,511AGAINST: 5,501,551
Details: description as filed, official tally, votes by 158 asset managers

Description as filed by funds: Ratification of the appointment of PricewaterhouseCoopers LLP ("PwC") as our independent registered public accounting firm for 2024; and

WEST PHARMACEUTICAL SERVICES INC.’s own tally for this item (“Proposal 5: Our shareholders ratified the selection of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the 2024 fiscal year by the following vote:”): 61,537,511 for, 5,501,551 against — passed, per its Form 8-K filed April 26, 2024 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “Proposal 5: Our shareholders ratified the selection of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the 2024 fiscal year by the following vote:”
Support: 92% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Also reported under other wordings, matched to the same row of WEST PHARMACEUTICAL SERVICES INC.’s official tally and shown with their own fund figures; their managers are not in the figures or the table on this card: “RATIFICATION OF THE APPOINTMENT OF PRICEWATERHOUSECOOPERS LLP (PWC") AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR 2024. "” (2 managers, 6,067 for, 249 against).

The 158 asset managers below reported 29,094,761 for, 71,825 against, 6,606 abstained.

FOR
FOR: 29,094,761AGAINST: 71,825ABSTAIN: 6,606
Largest asset managers voting on “Ratification of the appointment of PricewaterhouseCoopers LLP ("PwC") as our independent registered public acc” at WEST PHARMACEUTICAL SERVICES INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Vanguard8,724,5070 00For
BlackRock3,543,7000 00For
T. Rowe Price2,306,5240 00For
Fidelity1,888,1930 00For
FRANKLIN MANAGED TRUST1,322,7810 00For
State Street787,37720 00For
BARON INVESTMENT FUNDS TRUST (f/k/a BARON ASSET FUND)702,4040 00For
Brown Advisory Funds664,5640 00For
Invesco592,3410 00For
MFS538,3490 00For
Artisan528,7860 00For
ProShares502,7380 00For
JPMorgan470,9420 00For
TIAA460,5390 00For
Charles Schwab434,2270 00For
Jackson National339,8700 00For
Virtus308,3690 00For
FRANKLIN STRATEGIC SERIES305,6330 00For
Neuberger Berman284,9440 00For
Columbia Threadneedle279,6890 00For
CARILLON SERIES TRUST253,8180 00For
Waddell & Reed235,1870 00For
Bridge Builder Trust223,1250 00For
Victory Capital203,6430 00For
Prudential/PGIM203,1440 00For

Showing the 25 largest of 158 asset managers. See all 158 in the interactive database.

16. Shareholder Proposal Entitled "Simple Majority Vote"

No official matchCORPORATE GOVERNANCE

Combines 6 wordings of this item as funds reported it.

41% of fund votes cast · no official result

FORAGAINST
Details: votes by 152 asset managers

The 152 asset managers below reported 10,336,428 for, 15,155,251 against, 6,249 abstained. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 10,336,428AGAINST: 15,155,251ABSTAIN: 6,249
Largest asset managers voting on “Shareholder Proposal Entitled "Simple Majority Vote"” at WEST PHARMACEUTICAL SERVICES INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Vanguard8,9008,715,607 00Against
T. Rowe Price652,6841,653,840 00Mixed
Fidelity1,849,59438,599 00For
FRANKLIN MANAGED TRUST01,322,781 00Against
State Street787,284113 00For
BARON INVESTMENT FUNDS TRUST (f/k/a BARON ASSET FUND)702,4040 00For
Brown Advisory Funds0664,564 00Against
Invesco592,3410 00For
MFS538,3490 00For
Artisan528,7860 00For
ProShares502,7380 00For
JPMorgan470,9420 00For
TIAA460,5390 00For
Charles Schwab0434,227 00Against
Jackson National280,98558,885 00Mixed
Virtus13,090295,279 00Against
FRANKLIN STRATEGIC SERIES0305,633 00Against
Neuberger Berman0284,944 00Against
Columbia Threadneedle279,6890 00For
CARILLON SERIES TRUST253,8180 00For
Waddell & Reed235,1870 00For
Bridge Builder Trust177,70745,418 00Mixed
Victory Capital203,6430 00For
Prudential/PGIM36,830166,314 00Mixed
Dimensional172,4520 00For

Showing the 25 largest of 152 asset managers. See all 152 in the interactive database.

Largest WEST PHARMACEUTICAL SERVICES INC. shareholders voting in 2023-2024

Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 73,000,000 shares outstanding at the time of that meeting.

Fund voting reports: top WEST PHARMACEUTICAL SERVICES INC. shareholders by shares voted on “Advisory vote to approve named executive officer compensation;”, 2023-2024
#Asset manager % of shares outstanding
1Vanguard 11.95%
2BlackRock 4.85%
3Artisan 3.28%
4T. Rowe Price 3.16%
5Fidelity 2.59%
6FRANKLIN MANAGED TRUST 1.81%
7State Street 1.08%
8BARON INVESTMENT FUNDS TRUST (f/k/a BARON ASSET FUND) 0.96%
9Brown Advisory Funds 0.91%
10Invesco 0.81%
Institutional-manager reports: top WEST PHARMACEUTICAL SERVICES INC. shareholders by shares voted on “Advisory vote to approve named executive officer compensation;”, 2023-2024
#Asset manager % of shares outstanding
1Lazard 5.48%
2New York Life 5.48%
3T. Rowe Price 4.65%
4BlackRock 3.98%
5APG Asset Management US Inc. 3.30%
6FRANKLIN ADVISERS INC 3.05%
7State Street 2.75%
8Walter Scott & Partners Ltd 2.35%
9GEODE CAPITAL MANAGEMENT, LLC 2.31%
10BROWN ADVISORY INC 2.16%

Reported WEST PHARMACEUTICAL SERVICES INC. holdings and ownership

As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row names its form.

WEST PHARMACEUTICAL SERVICES INC. holdings and ownership disclosed for the 2023-2024 proxy season
Holder % outstanding Disclosure
Vanguard Group 13.29% 13F
BlackRock 8.84% 13F
BNY Mellon 4.51% 13F
State Street 4.41% 13F
Franklin Templeton 3.39% 13F
T. Rowe Price 2.78% 13F
Geode Capital 2.35% 13F
Morgan Stanley 2.03% 13F
Citadel Advisors 1.84% 13F
Invesco 1.05% 13F

Percentages above are of 73,000,000 shares outstanding, as reported by WEST PHARMACEUTICAL SERVICES INC. on its Form 10-Q dated March 31, 2024 (see the filing on EDGAR). This is the count contemporaneous with the 2023-2024 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from WEST PHARMACEUTICAL SERVICES INC.’s 10-Q dated March 31, 2024. This page is a static snapshot rebuilt weekly on October 14, 2026; a live search always shows the current data.

At WEST PHARMACEUTICAL SERVICES INC.'s shareholder meeting held April 23, 2024, in the 2023-2024 proxy season, 692 asset managers reported how they voted in their SEC Form N-PX filings, covering 12,433 separate fund positions. Their filings are grouped here into 16 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. On the most widely held item on that ballot — Advisory vote to approve named executive officer compensation; — WEST PHARMACEUTICAL SERVICES INC.'s filing reports the proposal as approved, with 95% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: WEST PHARMACEUTICAL SERVICES INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on April 26, 2024.

WEST PHARMACEUTICAL SERVICES INC. proxy season coverage: 2023-2024 (this page) · 2024-2025 · 2025-2026.

Download data (CSV): ballot items · votes by manager · column guide.